Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening

J Natl Compr Canc Netw. 2016 Nov;14(11):1479-1485. doi: 10.6004/jnccn.2016.0154.

Abstract

Colorectal cancer (CRC) remains a common cancer and significant public health burden. CRC-related mortality is declining, partly due to the early detection of CRC through robust screening. NCCN has established the NCCN Guidelines for CRC Screening to help healthcare providers make appropriate screening recommendations according to the patient's risk of developing CRC. This review describes the evolution of CRC screening guidelines for average-risk individuals, discusses the role of NCCN Guidelines for CRC Screening in cancer prevention, and comments on the current and emerging use of biomarkers for CRC screening.

Publication types

  • Practice Guideline
  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Colorectal Neoplasms / chemistry
  • Colorectal Neoplasms / diagnosis*
  • Early Detection of Cancer / methods
  • Early Detection of Cancer / standards*
  • Humans
  • Mass Screening / methods*

Substances

  • Biomarkers, Tumor